Emerge Diagnostics
Emerge Diagnostics
January 3, 2013
0 Emerge Diagnostics utilizes an FDA registered, class-II diagnostic device to provide our proprietary service, the Electrodiagnostic Functional Assessment (EFA). The EFA can objectively distinguish between chronic versus acute pathology, repetitive strain injuries, objectively quantify effort and assist with better treatment outcomes.
Related Projects:
Accele Biopharma / Venture Partners
accelerate
Accele Biopharma / Venture Partners
accelerate
Accele Biopharma / Venture Partners
accelerate
Accele Biopharma / Venture Partners
2016-01-03
Accolade Eternal Memorials
2016-01-02
Agric-Bioformatics
2015-12-30
Alkami Technology
2015-12-29
Amethyst Research Inc.
2015-12-28
Associated Material Processing
accelerate oscf
Associated Material Processing
accelerate oscf
Associated Material Processing
accelerate oscf
Associated Material Processing
2015-12-27
Arthrokinex
2015-12-26
